title: Coronary revascularization in multivessel disease. Which is better, stents or surgery?
abstract: Coronary artery disease (CAD) remains the major cardiovascular health issue in contemporary clinical practice. Treatment options for multivessel CAD include medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). Here, the authors review the most recent data that compare intracoronary stenting to CABG in multivessel disease. They address therapeutic issues surrounding proper selection of the optimal revascularization strategy and give special consideration to high-risk populations, such as patients with diabetes.
authors.affiliation: Rush Medical College, Rush University, Chicago, IL, USA. falmeda@aol.com
authors.forename: Francis Q
authors.initials: FQ
authors.lastname: Almeda
authors.forename: R Jeffrey
authors.initials: RJ
authors.lastname: Snell
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D009204:Myocardial Revascularization; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D015607:Stents; D016019:Survival Analysis